会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 13. 发明授权
    • Method of preparing bio-identical hormones
    • 制备生物相同激素的方法
    • US07563565B1
    • 2009-07-21
    • US12020670
    • 2008-01-28
    • Susan MatsuoTeresa Leigh Barr
    • Susan MatsuoTeresa Leigh Barr
    • C12Q3/00G01N31/00A61K36/258A61K31/56A61K31/568
    • A61K31/56A61K31/522A61K31/568Y10T436/10A61K2300/00
    • The embodied composition is a dose of bio-identical hormones in a solvent with a vasodilator, a hormone modulator, and a carrier for balancing and maintaining Cortisol level in a human. The dose comprises progesterone ranging from about 0.005 wt % to about 41 wt %; pregnenolone ranging from about 0.005 wt % to about 41 wt %; ethoxydiglycol ranging from about 0.005 wt % to about 10 wt %; pentoxifylline ranging from about 0.005 wt % to about 10 wt %; ginseng ranging from about 0.005 wt % to about 41 wt %, and carrier q.s. Embodied herein is a method for balancing and maintaining Cortisol levels in humans by identifying the hormonal needs for a human, testing to ascertain the baseline hormone levels, inserting the values of baseline hormone level for each hormone into a hormone tree, balancing the hormones to a normal level, adjusting the levels for symptoms and sex type, and forming a resultant composition.
    • 具体组合物是在具有血管扩张剂,激素调节剂和用于平衡和维持人皮质醇水平的载体的溶剂中的生物相同激素的剂量。 剂量包括约0.005重量%至约41重量%的孕酮; 孕烯醇酮的范围为约0.005重量%至约41重量%; 约0.005重量%至约10重量%的乙氧基二甘醇; 己酮可可碱的范围为约0.005wt%至约10wt%; 约0.005wt%至约41wt%的人参,和载体q.s. 本文所体现的是通过鉴定人的激素需求来平衡和维持皮质醇水平的方法,测试以确定基线激素水平,将每种激素的基线激素水平值插入激素树,将激素平衡至 正常水平,调整症状和性别水平,并形成所得组合物。
    • 17. 发明授权
    • Emu-based formulations with lidocaine for wound treatment by inhibiting microbial activity
    • 基于Emu的制剂,利多卡因用于通过抑制微生物活性进行伤口处理
    • US06998109B1
    • 2006-02-14
    • US10752820
    • 2004-01-07
    • Maurine PearsonTeresa Leigh Barr
    • Maurine PearsonTeresa Leigh Barr
    • A01N25/02A01N57/00A61K9/00A61K31/66A61K35/12
    • A61K31/66A61K35/57Y02A50/473Y02A50/481A61K2300/00
    • The present formulation is an analgesic, anesthetic and anti-pruritic formulation with from about 10.0 wt % to about 75.0 wt % Emu oil; from about 10.0 wt % to about 33.0 wt % benzyl alcohol; from about 0.25 wt % to about 5.0 wt % allantoin; from about 0.1 wt % to about 5.0 wt % methylparaben; from about 0.1 wt % to about 2.0 wt % propylparaben; and from about 0.5 wt % to about 4.0 wt % of lidocaine, wherein the formulation is adapted to inhibit microbial activity from Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecalis, Bacillus cereus, Candida albicans, Streptococcus agalactiae or combinations thereof, and wherein the lidocaine relieves pain on the epidermis of humans and animals of skin irritations, wounds, or burns.
    • 本发明的制剂是具有约10.0重量%至约75.0重量%Em油的止痛剂,麻醉剂和抗瘙痒剂制剂; 约10.0重量%至约33.0重量%的苄醇; 约0.25重量%至约5.0重量%的尿囊素; 约0.1重量%至约5.0重量%的对羟基苯甲酸甲酯; 约0.1重量%至约2.0重量%的对羟基苯甲酸丙酯; 和约0.5重量%至约4.0重量%的利多卡因,其中该制剂适于抑制来自大肠杆菌,鼠伤寒沙门氏菌,铜绿假单胞菌,金黄色葡萄球菌,粪肠球菌,蜡状芽孢杆菌,白色念珠菌,无乳链球菌或其组合的微生物活性 ,并且其中利多卡因缓解人和动物皮肤刺激,伤口或灼伤的表皮上的疼痛。
    • 19. 发明授权
    • Bio-identical hormones and method of use
    • 生物相同的激素和使用方法
    • US06967194B1
    • 2005-11-22
    • US10246358
    • 2002-09-18
    • Susan MatsuoTeresa Leigh Barr
    • Susan MatsuoTeresa Leigh Barr
    • A01K31/56A01K31/58
    • A61K31/56A61K31/522A61K31/568Y10T436/10A61K2300/00
    • The invention is a method for balancing and maintaining Cortisol levels in humans by identifying the hormonal needs for a human, using blood tests or saliva tests to ascertain the current relationship between the DHEA, androstenedione, testosterone and androstenediol for that human, inserting the low values of each hormone level into a hormone tree, balancing the DHEA with the androstenediol and the testosterone and the androstenediol in a ratio which is normal for the particular person, modifying the inserted values individually forming modified values wherein the modified values account for a selected symptoms, changing the modified value to accommodate for sex type of an individual forming a gender accommodated value, and creating a morning and evening dose that priors an amount of bio-identical hormones to bring the gender accommodated value up to the normal ratio.
    • 本发明是通过鉴定人的激素需求来平衡和维持人类皮质醇水平的方法,使用血液测试或唾液测试来确定DHEA,雄烯二酮,睾酮和雄烯二醇之间目前的关系,插入低值 将每种激素水平转化成激素树,将DHEA与雄烯二醇和睾酮和雄烯二醇平衡,其比例对于特定的人是正常的,修饰插入的值分别形成修饰值,其中修饰值表示所选择的症状, 改变修改值以适应形成性别平等价值的个体的性别类型,并创建一个早晚剂量,以提供一定量的生物相同激素,使性别平等值达到正常比例。